1-2 of 2
Sam Ackroyd, MD
Close
Sort by
Journal Articles

A Retrospective Real-World Study of the Current Treatment Pathways for Myelofibrosis in the UK (The REALISM UK Study)

Adam J. Mead, MD PhD, Tim Somervaille, Professor, MD, Nauman M Butt, MD, Waseem Nagi, MD FRCPath, Alastair J Whiteway, MBBS, Suriya Kirkpatrick, MD, Ciro R Rinaldi, MD PhD, Catherine Roughley, MD, Sam Ackroyd, MD, Joanne Ewing, PhDBMBS BSc FRPATH, Pratap Neelakantan, MD FRCPath, Mamta Garg, MD FRCP, FRCPath, Claire N Harrison, Professor, David Tucker, MD, Rozinder Bains, Gavin Chiu, MBBS, MRCGP, MFPM, DPM, BSc, Joe Hickey, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1671.
https://doi.org/10.1182/blood-2019-124686
Published: 2019
Journal Articles

Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival

Marlijn Hoeks, MD, Tim Bagguley, MS, Rian Roelofs, Msc, Louise De Swart, MD, David Bowen, MD PhD, Argiris Symeonidis, MD PhD, Corine van Marrewijk, PhD, Eva Hellström-Lindberg, MD PhD, Aurelia Tatic, MD, Saskia Langemeijer, MD PhD, Dominic J. Culligan, Marian Macheta, MD, Hege Garelius, MD, Michail Spanoudakis, MD, Sally Killick, MD, Panagiotis Panagiotidis, MD PhD, Oana Stanca Ciocan, MD, Juliet Mills, MD, Bryson Pottinger, Sam Ackroyd, MD, Claire Hall, MD, Jackie Droste, PhD, Alexandra Smith, PhD, Dorine W. Swinkels, MD PhD, Theo M de Witte, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4392.
https://doi.org/10.1182/blood-2018-99-118070
Published: 2018